Blood eosinophil count correlates with severity of respiratory failure in life‐threatening asthma and predicts risk of subsequent exacerbations

Abstract

Background An elevated blood eosinophil count when asthma is stable predicts exacerbations and therapeutic response to corticosteroids or biologics targeting eosinophils. Few studies have examined the prognostic value of blood eosinophils measured at exacerbation. Aim To elucidate the relationship between a spot blood eosinophil count–measured at the onset of a life‐threatening asthma exacerbation–with indices of exacerbation severity and risk of subsequent exacerbations. Methods Real‐world, retrospective review of all life‐threatening asthma cases admitted at 4 public hospitals in Singapore between 2011‐2015. We assessed the trends and correlations between blood eosinophil count on admission with arterial blood gas values, duration of mechanical ventilation, and risk of death, hypoxic ischemic encephalopathy or respiratory arrest. Risk of future exacerbations among survivors was modelled using Cox regression and survival curves. Results There were 376 index life‐threatening exacerbations with median blood eosinophil count (5‐95th percentiles) of 0.270 × 109/L (0‐1.410 × 109/L). Arterial pH decreased and PCO2 increased with increasing eosinophil count. Duration of mechanical ventilation and risk of death, hypoxic ischaemic encephalopathy or respiratory arrest did not vary with eosinophils. Among 329 survivors who were followed‐up over a median of 52 months, blood eosinophils ≥1.200 × 109/L was associated with an increased hazard of emergency visits and/or admissions for asthma (hazard ratio 1.8, 95% confidence interval 1.1‐2.9, P = .02). Conclusion In this study of life‐threatening asthma, we found that a spot blood eosinophil count correlates with severity of respiratory failure and predicts risk of subsequent exacerbations.

Improving asthma care with Asthma-COPD Afterhours Respiratory Nurse at Emergency (A-CARE)

“…This represents a critical gap in asthma care to be urgently addressed via better implementation of quality asthma care. Failure to provide ICS controller medication and follow-up assessment have been consistently cited as avoidable factors in national audits of patients with fatal or near-fatal asthma in Singapore 36 and internationally, 37 38 and our study has shown that it is possible to address them with extended availability of specialist asthma nurse counselling after-hours.…”

Developments allergy in 2019 through the eyes of Clinical and Experimental Allergy, Part II clinical allergy

“…53 Although a retrospective review, the study by Yii and colleagues related blood eosinophils on admission during a life-threatening asthma attack, to clinical parameters such as arterial blood gases and duration of mechanical ventilation. 54 The acute blood eosinophil count on admission did not relate to outcome for the acute admission. However, an admission eosinophil count of A biomarker that is now part of diagnostic guidelines for asthma in both children and adults is an elevated exhaled nitric oxide (FeNO) level.…”

Needs for Systems Approaches to Better Treat Individuals With Severe Asthma: Predicting Phenotypes and Responses to Treatments

“…Blood eosinophil count >115 cells/mm 3 were significantly though weakly correlated with a T2-high signature (38). Despite being a poor biomarker in determining asthma phenotype, high blood eosinophil counts (>1,200 cells/mm 3 ) were recently associated with a higher risk of recurrent exacerbations in patients admitted to the ICU for near-fatal asthma (39).…”